Carlyle Acquires Tarrytown Expocare Pharmacy from Sheridan Capital Partners

Carlyle Acquires Tarrytown Expocare Pharmacy from Sheridan Capital Partners

November 14, 2025

Healthcare Services

Funds managed by global investment firm Carlyle have completed the acquisition of Tarrytown Expocare Pharmacy from Sheridan Capital Partners, with Sheridan retaining a minority stake. Tarrytown is a specialized long-term care pharmacy serving the intellectual & developmental disability (IDD) and behavioral health communities; Carlyle said it will invest to expand the company's footprint and capabilities nationwide.

Tarrytown Expocare Pharmacy Acquires Greater Boston Long Term Care Pharmacy

December 16, 2024

Healthcare Services

Tarrytown Expocare Pharmacy, a national long-term care pharmacy focused on IDD and behavioral health, has acquired Greater Boston Long Term Care Pharmacy to establish a Massachusetts presence. The deal, supported by Sheridan Capital Partners and advised on the sell-side by M&A Healthcare Advisors, adds a regional location to Tarrytown's platform and aims to expand services to group homes and assisted living communities across the Commonwealth.

Carlyle and Consonance Partner with Orsini Specialty Pharmacy

February 11, 2022

Healthcare Services

Funds managed by global investment firm Carlyle have joined Consonance Capital Partners in a strategic partnership with Orsini Specialty Pharmacy to support expansion of patient access and high-touch support services for rare diseases, gene therapies and complex conditions. Terms were not disclosed; the investment is intended to strengthen Orsini’s service offerings for patients, manufacturers and payors and accelerate growth.

EXA Capital Acquires PrecisionCare

February 24, 2025

Healthcare Services

EXA Capital has acquired PrecisionCare, a New York–founded SaaS provider of electronic health records and care management solutions serving behavioral health and long-term care providers. PrecisionCare’s management will remain in place as EXA leverages its buy-and-hold strategy and operational resources to accelerate product development, scale market reach, and expand capabilities in healthcare technology.

Carlyle and PAI Partners Acquire Theramex from CVC Capital Partners

March 28, 2022

Pharmaceuticals

Global private equity firms Carlyle and PAI Partners have agreed to acquire Theramex, a London-based specialty pharmaceuticals company focused on women's health, from CVC Capital Partners VI. The new owners plan to accelerate Theramex's international expansion and broaden its women's health product suite to drive further organic and inorganic growth.

Carlyle Acquires Abingworth to Expand Global Healthcare & Life Sciences Investing

August 3, 2022

Healthcare Services

Global investment firm Carlyle has acquired Abingworth, a transatlantic life sciences investment firm with about $2 billion in assets under management, to broaden Carlyle's healthcare franchise and capabilities across venture to buyouts. The deal brings Abingworth's specialized team and clinical co-development expertise into Carlyle and establishes Launch Therapeutics, an operating company to accelerate late-stage clinical development; terms were not disclosed.